Cholesteryl ester transfer protein inhibitors

Details for Australian Patent Application No. 2006335109 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Ali, Amjad; Taylor, Gayle E.; Sinclair, Peter J.

Agent Spruson & Ferguson

Pub. Number AU-B-2006335109

PCT Pub. Number WO2007/081570

Priority 60/755,201 30.12.05 US

Filing date 29 December 2006

Wipo publication date 19 July 2007

Acceptance publication date 7 April 2011

International Classifications

C07D 265/10 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

3 July 2008 PCT application entered the National Phase

  PCT publication WO2007/081570 Priority application(s): WO2007/081570

28 January 2010 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

7 April 2011 Application Accepted

  Published as AU-B-2006335109

4 August 2011 Standard Patent Sealed

11 October 2012 Alteration of Name

  The name of the patentee has been altered to Merck Sharp & Dohme Corp. Amendments

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006335110-CETP inhibitors

2006335108-CETP inhibitors